Sentence: The combination of 1-hour paclitaxel , carboplatin , and extended oral schedule etoposide is feasible and well tolerated at the doses administered in this phase II trial .
Drug combination annotation:
[{'class': 'POS', 'spans': ['paclitaxel', 'carboplatin', 'etoposide'], 'is_context_needed': False}]